Addus HomeCare (ADUS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Jun, 2026Opening remarks and agenda
Meeting called to order virtually at 10:00 A.M. Central Time on June 10, 2026, with executive officers and board members present.
Chairman and secretary roles established; procedural rules and order of business aligned with the proxy statement.
Agenda included election of directors, auditor ratification, and executive compensation approval.
Corporate governance
Quorum confirmed with shareholders present virtually or by proxy, representing a majority of eligible votes.
Only company-nominated directors were considered, as no shareholder nominations were submitted.
Board and executive committee updates
Two Class 2 directors, Michael Earley and Veronica Hill-Milbourne, nominated for three-year terms.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Addus HomeCare
- Q2 2026 revenue rose 8% to $377.4M, with net income up 25.2% and strong cash flow fueling growth.ADUS
Q2 2026 - PCS growth, tech adoption, and M&A drive expansion amid stable regulatory and financial outlook.ADUS
RBC Capital Markets Global Healthcare Conference 2026 - Census and hours growth accelerate with tech adoption, supporting balanced expansion and M&A.ADUS
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue up 7.7%, net income up 18.1%, driven by personal care and hospice growth.ADUS
Q1 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ADUS
Proxy filing - Q3 revenue up 7%, EPS up 13%, Gentiva deal to close Q4, New York exit, liquidity strong.ADUS
Q3 2024 - Q2 revenue up 10.4%, net income up 21.7%, and $350M Gentiva acquisition announced.ADUS
Q2 2024 - Regulatory clarity, strong hiring, and M&A focus drive growth and expansion plans.ADUS
Jefferies 2024 Global Healthcare Conference - Q1 2025 delivered 20% revenue growth and margin gains, led by personal care and acquisitions.ADUS
Q1 2025